📰 Chris Bunka News
Chris Bunka News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chris Bunka. Real-time updates on events, politics, business and more.
May 23, 2024
First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company"
April 30, 2024
Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise ...
November 2, 2023
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
October 24, 2023
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
September 6, 2023
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
August 9, 2023
Lexarias DehydraTECH-Nicotine Faster than ZYN and on!
July 6, 2023
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
June 12, 2023
KELOWNA, BC / ACCESSWIRE / June 12, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of
June 7, 2023
Lexaria Biosciences powerful, proprietary drug delivery technology, DehydraTECH has the potential to disrupt multiple categories as the company continues to receive positive results from clinical... | June 7, 2023
May 12, 2023
Lxrp_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... | May 12, 2023